Down-regulation of tissue factor by siRNA increased doxorubicin-induced apoptosis in human neuroblastoma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 28, Issue 1, 2008, Pages 42-45

  Fang, Jun ^a   Tang, Hao ^b   Xia, Linghui ^a   Zhou, Muxiang ^c   Chen, Yan ^a   Wei, Wenning ^a   Hu, Yu ^a   Song, Shanjun ^a   Hong, Mei ^d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN NO 1 HOSPITAL   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Apoptosis; Chemotherapy; Neuroblastoma; Tissue factor

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CASPASE 3; DOXORUBICIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALL INTERFERING RNA; THROMBOPLASTIN;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; IC 50; METABOLISM; NEUROBLASTOMA; TIME;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; DOWN-REGULATION; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, BIOLOGICAL; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; RNA, SMALL INTERFERING; THROMBOPLASTIN; TIME FACTORS;

EID: 39349100535     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0110-0     Document Type: Article

References (13)

1. Versteeg H H, Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost, 2006,32:24-32
2. Fang J, Song S J. Nonthrombotic function of tissue factor. Zhonghua Xue Ye Xue Za Zhi (Chinese), 2002; 24(3):184-186
3. Brummelkamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002,296:550-553
4. Holen T, Amarzguioui M, Wiiger M T et al. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res, 2002,30:1757-1766
5. Peskin A V, Winterbourn C C. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin Chim Acta, 2000,293:157-166
6. Forster Y, Meye A, Albrecht S et al. Tissue factor and tumor: clinical and laboratory aspects. Clin Chim Acta, 2006,364:12-21
7. Fang J, Wei W N, Xia L H et al. The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer. Zhonghua Xue Ye Xue Za Zhi (Chinese). 2004,25(9):523-527
8. Rak J, Milsom C, May L et al. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost, 2006,32:54-70
9. Vermeulen K, Van Bockstaele D R, Berneman Z N. Apoptosis: mechanisms and relevance in cancer. Ann Hematol, 2005,84:627-639
10. Sorensen B B, Rao L V, Tornehave D et al. Antiapoptotic effect of coagulation factor VIIa. Blood, 2003,102:1708-1715
11. Versteeg H H, Spek C A, Richel D J et al. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene, 2004,23:410-417
12. Mizutani H, Tada-Oikawa S, Hiraku Y et al. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci, 2005,76:1439-1453
13. Kim D, Cheng G Z, Lindsley C W et al. Targeting the phosphatidylinositol- 3 kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs, 2005,6:1250-1258